<blockquote>
 <p>
  GlaxoSmithKline is recalling nearly 600,000 prescription inhalers over defects, the FDA announced.
 </p>
 <p>
  The voluntary recall targets Ventolin HFA (albuterol sulfate) Inhalation Aerosol, distributed via prescription nationwide.
  <br>
   The manufacturer said the drug delivery system is defective.
  </br>
 </p>
</blockquote>
